News | Ablation Systems | May 21, 2018

First Human Cases Treated With Globe Multi-electrode Contact Mapping and Ablation System

Study at Heart Rhythm 2018 shows very good efficacy in treating atrial fibrillation

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in-man study using the Kardia Globe multi-electrode array catheter ablation system. The late-breaking study was presented at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

The Kardium Globe Mapping and Ablation System is a complete, combined system intended to assist in the diagnosis and treatment of atrial fibrillation (AF). A big question for technological advancement of Afib catheter ablation has been whether the creative new concept of a diagnostic mapping options of single-tip and basket catheters combined with the simplicity of using balloon catheters for ablation would work to quickly and accurately to isolate the pulmonary veins.

Authors of the study said the new device offers a easy handling and fast single-shot pulmonary vein isolation (PVI). It continuously updates several mapping types (e.g. voltage mapping, activation mapping) from all 122 electrodes on the device in real-time during ablation, This feature  demonstrated in study a unique capability to go beyond PVI for substrate description plus ablation, and for rotor mapping plus rotor ablation with a single catheter.

The Globe device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. It was used prospectively in 60 patients (mean age 64±10 years, 58 patients with paroxysmal AF) in two centers (Hirslanden Hospital, Zurich and Heart Center, Leipzig). Each electrode can record electrograms, ablate, pace and can measure tissue contact, temperature, and current. Ablation can be done with up to 24 electrodes simultaneously. The amount of current delivered to each electrode to maintain the target electrode temperature (57-65°C) is automatically controlled. 

Immediate automatic down regulation of power is provided in case of intermittent loss of contact from such causes as deep breath.

The study's first six and 12-month follow-up data show complete PVI) was achieved in 234/236 veins (99.2 percent) of patients. Procedure time and fluoroscopy time measured 147±45 and 11±4 minutes, respectively. In two patients, cardiac tamponade was observed (3 percent), and no cases of stroke, PV stenosis, esophageal perforation or phrenic nerve paresis were observed.

Find links to all the Heart Rhythm 2018 Late-breaking Studies

Related Content

Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically
Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
Overlay Init